DataKnowledgeCloudtrainingcoordination

HEK293 (Subject)

Taxonomy Id:

Homo sapiens

Taxonomy (Entity type)

Role Id:

cell line ancestor

Subject Role (Entity type)

Project:

LINCS

Project (Entity type)

Granularity:

cell line

Subject Granularity (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 REP.A014 HEK293 24H K22 narlaprevir 0.37uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.B017 HEK293 24H L16 cilostazol 0.08uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A026 HEK293 24H N04 desvenlafaxine 0.37uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.B024 HEK293 24H A07 ST-1859 2.22uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC REP.A010 HEK293 24H M09 alaproclate 1.11uM.tsv.gz File (Entity type)	A 166 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.B009 HEK293 24H O05 MG-132 20uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC LJP007 HEK293 24H A21 TPCA-1 1.11uM.tsv.gz File (Entity type)	A 216 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.B012 HEK293 24H B03 DMSO Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A018 HEK293 24H L18 avanafil 0.04uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A015 HEK293 24H O22 emtricitabine 0.37uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.A014 HEK293 24H K22 narlaprevir 0.37uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.B017 HEK293 24H L16 cilostazol 0.08uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.A026 HEK293 24H N04 desvenlafaxine 0.37uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.B024 HEK293 24H A07 ST-1859 2.22uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC REP.A010 HEK293 24H M09 alaproclate 1.11uM.tsv.gz

File (Entity type)

A 166 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.B009 HEK293 24H O05 MG-132 20uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC LJP007 HEK293 24H A21 TPCA-1 1.11uM.tsv.gz

File (Entity type)

A 216 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.B012 HEK293 24H B03 DMSO

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.A018 HEK293 24H L18 avanafil 0.04uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.A015 HEK293 24H O22 emtricitabine 0.37uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.